Published on in Vol 9, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/16319, first published .
Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

Integration of Mobile Health Into Sickle Cell Disease Care to Increase Hydroxyurea Utilization: Protocol for an Efficacy and Implementation Study

Jane S Hankins 1*, MD, MS;  Nirmish Shah 2*, MD;  Lisa DiMartino 3, PhD, MPH;  Donald Brambilla 3, PhD;  Maria E Fernandez 4, PhD;  Robert W Gibson 5, PhD;  Victor R Gordeuk 6, MD;  Richard Lottenberg 7, MD;  Abdullah Kutlar 5, MD;  Cathy Melvin 8, PhD;  Jena Simon 9, MS, APRN;  Ted Wun 10, MD;  Marsha Treadwell 11, PhD;  Cecelia Calhoun 12, MD;  Ana Baumann 12, PhD;  Michael B Potter 13, PhD;  Lisa Klesges 12, PhD;  Hayden Bosworth 2, PhD;   Sickle Cell Disease Implementation Consortium 14*

1 St. Jude Childrens Research Hospital , Memphis, TN, US

2 Department of Medicine, Duke University , Durham, NC, US

3 Research Triangle Institute , Research Triangle Park, NC, US

4 University of Texas Health Science Center at Houston School of Public Health , Houston, TX, US

5 Center for Blood Disorders, Medical College of Georgia, Augusta University, Augusta, GA, US

6 Division of Hematology and Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, IL, US

7 Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainsville, FL, US

8 Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC, US

9 Ichan School of Medicine at Mount Sinai , New York, NY, US

10 Division of Hematology Oncology, UC Davis School of Medicine , Davis, CA, US

11 University of California San Francisco Benioff Children Hospital Oakland , Oakland, CA, US

12 Division of Hematology Oncology, Department of Pediatrics, Washington University, St. Louis, MO, US

13 University of California San Francisco School of Medicine , San Francisco, CA, US

14 , Bethesda, MA, US

*these authors contributed equally

Corresponding Author: